QC
AUPH icon

Quantessence Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Quantessence Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,822
Closed -$100K – 187
2025
Q2 		$100K Buy
+11,822
New +$94.8K 0.03% 173

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantessence Capital's AUPH Position: Q3 2025 in Review

Quantessence Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2025, closing a stake of 11,822 shares — an estimated $100K sold.

Quantessence Capital first reported a position in AUPH in Q2 2025 and held it in 1 quarter. The position peaked at $100K in Q2 2025. 242 funds tracked by Wall St. Rank hold AUPH as of Q3 2025.

  • Quantessence Capital reported no remaining Aurinia Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Quantessence Capital sold 11,822 Aurinia Pharmaceuticals shares in Q3 2025, an estimated $100K.
  • Quantessence Capital first reported a position in Aurinia Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Quantessence Capital's Aurinia Pharmaceuticals position peaked at $100K in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.